Systemic and pulmonary C1q as biomarker of progressive disease in experimental non-human primate tuberculosis
Open Access
- 14 April 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-12
Abstract
Tuberculosis (TB) causes 1.6 million deaths annually. Early differential diagnosis of active TB infection is essential in optimizing treatment and reducing TB mortality, but is hampered by a lack of accurate and accessible diagnostics. Previously, we reported on complement component C1q, measured in serum by ELISA, as a candidate biomarker for active tuberculosis. In this work we further examine the dynamics of C1q as a marker of progressive TB disease in non-human primates (NHP). We assessed systemic and pulmonary C1q levels after experimental infection using high or low single dose as well as repeated limiting dose Mycobacterium tuberculosis (Mtb) challenge of macaques. We show that increasing C1q levels, either peripherally or locally, correlate with progressive TB disease, assessed by PET-CT imaging or post-mortem evaluation. Upregulation of C1q did not precede detection of Mtb infection by a conventional interferon-gamma release assay, confirming its association with disease progression. Finally, pulmonary vaccination with Bacillus Calmette Guérin also increased local production of C1q, which might contribute to the generation of pulmonary protective immunity. Our data demonstrate that NHP modelling of TB can be utilized to study the role of C1q as a liquid biomarker in TB protection and disease, complementing findings in TB patients.Keywords
Funding Information
- EC | Horizon 2020 Framework Programme (643381)
This publication has 44 references indexed in Scilit:
- Tuberculosis: advances and challenges in development of new diagnostics and biomarkersThe Lancet Infectious Diseases, 2018
- Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosisProceedings of the National Academy of Sciences, 2018
- Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis diseasePLOS Pathogens, 2017
- Discovery and Validation of a Six-Marker Serum Protein Signature for the Diagnosis of Active Pulmonary TuberculosisJournal of Clinical Microbiology, 2017
- C1q: A fresh look upon an old moleculeMolecular Immunology, 2017
- Serum amyloid A, protein Z, and C4b-binding protein β chain as new potential biomarkers for pulmonary tuberculosisPLOS ONE, 2017
- Screening and identification of five serum proteins as novel potential biomarkers for cured pulmonary tuberculosisScientific Reports, 2015
- Tuberculosis Diagnostics in 2015: Landscape, Priorities, Needs, and ProspectsThe Journal of Infectious Diseases, 2015
- Complement, C1q, and C1q-Related Molecules Regulate Macrophage PolarizationFrontiers in Immunology, 2014
- Distinct Phases of Blood Gene Expression Pattern Through Tuberculosis Treatment Reflect Modulation of the Humoral Immune ResponseThe Journal of Infectious Diseases, 2012